TEG^® 5000

With more than a decade of clinical experience in the U.S. and over 4,000 peer-reviewed articles published, the clinical and economic value of the TEG^® testing system is well-established. Adding the TEG 5000 haemostasis system to your haemostasis management program can help improve patient outcomes and may decrease healthcare costs.

The TEG 5000 system uses a cup and pin mechanism to measure the elastic motion of whole blood clot formation. During coagulation the blood adheres onto the surfaces of the cup and pin and the mechanical strength of the blood clot is continuously determined.

The TEG^® 5000 system offers a broad portfolio of assays. The system has the flexibility to perform one or more assays such as Kaolin, RapidTEG^™, Functional Fibrinogen and PlateletMapping^®.

TEG assays are compatible with both citrated and non-citrated whole blood samples. Non-citrated whole blood allows for immediate processing of a syringe-drawn sample without added expense and transfer time. Citrated samples prevent clotting to delay testing for up to 2 hours. Citrate is easily reversed by calcium chloride.

TEG Manager software provides secure, on-demand access to patient results anywhere within the hospital network.

With our Interpretation Guidance module, clinical alert messages can be configured according to your institution’s guidelines, providing standardised practice and efficient test interpretation for all users.